The histone demethylase Jarid1b mediates angiotensin II-induced endothelial dysfunction by controlling the 3'UTR of soluble epoxide hydrolase.
Andrea E VasconezPatrick JanetzkoJames A OoBeatrice Pflüger-MüllerCorina RatiuLunda GuKristian HelinGerd GeisslingerIngrid FlemingKatrin SchröderChristian ForkRalf P BrandesMatthias S LeisegangPublished in: Acta physiologica (Oxford, England) (2018)
Jarid1b contributes to the pro-inflammatory effects of AngII by stabilizing sEH expression. Jarid1b inhibition might be an option for future therapeutics against cardiovascular dysfunction.